This infographic highlights the role of APRIL in a pre-hit 1 step that drives the 4-hit cascade.1 References 1. Mathur M, et al. J Clin Med. 2023;12(21):6927. Read More
On June 27, 2024, the Centers for Medicare & Medicaid Services (CMS) issued a proposed rule to update payment rates and policies and includes requests for information under the End-Stage… Read More
This podcast with the AKF will help highlight the meaningful work they do to ensure that patients with kidney disease get the diagnosis they need and the care they deserve. Read More
This webinar panel discussion featuring Dr. Naoka Murakami and Kelly Chen, NP-BC will discuss the prevalence of various common and rare kidney diseases and comorbidities among the Asian American and… Read More
Join us for this webinar to learn more about mental health in IgAN and how it impacts patients, caregivers, healthcare providers, as well as related stressors. Read More
The goal of this podcast is to discuss the evidence that supports proteinuria reduction as a surrogate marker in IgA Nephropathy clinical trials. Read More
Learn about the International IgA Nephropathy Prediction Tool (IIgAN-PT), the preferred prediction tool for time of kidney biopsy. Read More
NephU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) and Otsuka America Pharmaceutical, Inc. (OAPI) - committed supporters of the Kidney Health Community. The information provided through NephU is intended for the educational benefit of health care professionals and others who support care for those with kidney disease and other related conditions. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing NephU’s educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by NephU. Some of the contributors may be paid consultants of OPDC and/or OAPI.